Welcome to the e-CCO Library!

P099: Postprandial intestinal motility and related physiology in active small-bowel Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Khalaf1,2, C.L. Hoad2,3, A. Menys4, S. Radford2, A. Nowak2, S. Paparo1,2, M. Lingaya2, Y. Falcone2, G. Singh2, S.A. Taylor4, R.C. Spiller1,2, P.A. Gowland3, L. Marciani1,2, G.W. Moran1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P099: Serum proteomic analysis reveals novel biomarkers associated with disease activity in pediatric patients with Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Werner, L.(1);Weiss, B.(2);Matar, M.(1);Shamir, R.(1);Shouval, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P100 CD161 levels are reduced in all subpopulations of T-cell colonic mucosal lymphocytes in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Tristan, A. Carrasco, A. Martín-Cardona, Y. Zabana, M. Aceituno, A. Raga, X. Andújar, B. Arau, P. Ruiz-Ramírez, L. Ruiz-Campos, F. Fernández-Bañares, M. Esteve

Created: Thursday, 30 January 2020, 10:12 AM
P100: Atypical Anti-Neutrophil Cytoplasmatic Antibodies Are Antibodies Against Neutrophil Extracellular Traps: A Novel Pathophysiological Mechanism In Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mendieta Escalante, E.A.(1)*;Faber, K.N.(1);Hermoso Ramello, M.(1);Parada-Venegas, D.(1);Bourgonje, A.(2);Roozendaal, C.(3);Dijkstra, G.(1);
Created: Friday, 14 July 2023, 10:48 AM
P100: Effects of a narrow spectrum kinase inhibitor and selective kinase inhibitors on the intestinal pro-inflammatory immune response in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. R. Foster*1, P. Biancheri2, Y. Solanke1, S. Sirohi1, M. C. Fyfe1, A. Rowley1, T. T. MacDonald2, E. Wood3, S. Webber1, C. A. Walshe1

Created: Friday, 22 February 2019, 9:49 AM
P100: Guanosine prevents nuclear factor-κB nuclear translocation ameliorating experimental colitis in rats
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.G. Zizzo1,2*, G. Caldara3, A. Bellanca2, D. Nuzzo4, M. Di Carlo4, R. Serio1

Created: Thursday, 21 February 2019, 9:14 AM
P100: Higher yield of serrated and adenomatous dysplasia detected with chromoendoscopy when compared with high-definition in patients with Primary Sclerosing Cholangitis and Inflammatory colitis.
Year: 2021
Source: ECCO'21 Virtual
Authors: Gupta, V.(1);Hartery, K.(2);Oxford IBD Cohort Investigators, I.(2);Bassett, P.(2);Culver, E.(2);East, J.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P100: Intestinal epithelial cells under endoplasmic reticulum stress boosts serine proteolytic activity and modulates barrier function
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Solà Tapias N., Denadai-Souza A., Rolland-Fourcade C., Blanpied C., Dietrich G., Bonnart C., Edir A., Rolland C., Deraison C., Vergnolle N., Barreau F.

Created: Wednesday, 20 February 2019, 10:36 AM
P100: Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

V. Cheung*1, T. Gupta1, A. Olsson-Brown2, S. Subramanian3, M. Payne4, M. Middleton4, O. Brain1

Created: Friday, 22 February 2019, 9:41 AM
P100: Serum inflammatory protein profiling to corroborate selection of therapy naïve moderate-to-severe pediatric Crohn’s disease patients eligible for first-line infliximab treatment
Year: 2022
Source: ECCO'22
Authors: Jongsma , M.M.E.(1);Costes , L.M.M.(2);Tindemans , I.(2);Cozijnsen , M.A.(1);Raatgreep , R.H.C.(2);van Pieterson , M.(1);Li , Y.(3);Escher , J.C.(1);de Ridder , L.(1);Samsom , J.N.(2);
Created: Friday, 11 February 2022, 3:52 PM
P101 Biomarkers of elastin degradation are associated with clinical and biochemically active disease in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Pehrsson1, V. Domislović2, M.A. Karsdal1, M. Brinar2, A. Barisic3, Z. Krznaric2, T. Manon-Jensen1, J.H. Mortensen1

Created: Thursday, 30 January 2020, 10:12 AM
P101: Circulating MicroRNA-16 in Inflammatory Bowel Disease Patients - Potential Biomarker to Assess Inflammation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Atanassova, A.(1);GeorgievaPhD, A.C.(1)*;
Created: Friday, 14 July 2023, 10:48 AM
P101: Fecal calprotectin is increased among patients with pouchitis and increases with increasing endoscopic subscores: Real-world data from a prospectively collected database
Year: 2021
Source: ECCO'21 Virtual
Authors: Ollech, J.(1);Bannon, L.(2);Maharshak, N.(2);Tulchinsky, H.(2);Yanai, H.(1);Dotan, I.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P101: Functional translation of IBD-associated genetic variation in patient-derived intestinal epithelial cells
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

W. Vanhove*1, K. Nys1, I. Arijs1, I. Cleynen2, G. Van Assche1, M. Ferrante1, S. Vermeire1

Created: Friday, 22 February 2019, 9:49 AM
P101: Innate immunity and Crohn’s disease recurrence after surgery
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Saadeh1*, I. Angriman1, A. Kotsafti2, C. Mescoli3, T. Odorizzi1, M. Scarpa2, F. Cavallin2, M. Rugge4, R. Bardini1, I. Castagliuolo5, M. Scarpa2

Created: Thursday, 21 February 2019, 9:14 AM
P101: Interleukin-13 induces polarity defects in the intestinal epithelia
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lebenheim L., Kühnel A., Hering N., Bojarski C., Schulzke J.-D., Siegmund B., Schumann M.

Created: Wednesday, 20 February 2019, 10:36 AM
P101: Isosteviol Attenuates Dextran Sulfate Sodium-Induced Colitis by Maintaining the Intestinal Barrier Through PDK1/AKT/NF-κB Signaling
Year: 2022
Source: ECCO'22
Authors: Yao, L.(1);Cao, Q.(1);
Created: Friday, 11 February 2022, 3:52 PM
P101: Simple five-point classification of MR enterocolonography for Crohn’s disease based on enteroscopic findings
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Fujii*1, Y. Kitazume2, K. Takenaka1, K. Suzuki1, M. Motobayashi1, E. Saito1, M. Nagahori1, K. Ohtsuka1, M. Watanabe1

Created: Friday, 22 February 2019, 9:41 AM
P102 Host gene background and concentration influence the butyrate effect on modulating IECs proliferation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. He1, J. Hu2, W. Wang2, M. Zhang2, M. Zheng2, X. Peng2, Y. Zhang2, M. Zhou2, T. Liu2, J. Zhao2, Q. Zhang2, M. Zhi2,1

Created: Thursday, 30 January 2020, 10:12 AM
P102: α-Defensins(αDef) 1-3 are specific plasmatic markers for Crohn’s disease (CD) at diagnosis and tissue α-Def 5 methylation is a pathogenic mechanism for αDef-5 down regulation in CD.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Cerrillo1, I. Moret-Tatay2,3, M. Iborra1,2, E. Sáez-González1, E. Busó4, D. Ramos5, L. Tortosa1, P. Nos1,3, B. Beltrán*1,3

Created: Friday, 22 February 2019, 9:49 AM